PRVRX
Price
$13.11
Change
+$0.10 (+0.77%)
Updated
Jul 3 closing price
Net Assets
253.82M
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

PRVRX vs VVIAX

Header iconPRVRX vs VVIAX Comparison
Open Charts PRVRX vs VVIAXBanner chart's image
PGIM Quant Solutions Large-Cap Val R
Price$13.11
Change+$0.10 (+0.77%)
VolumeN/A
Net Assets253.82M
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
PRVRX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PRVRX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRVRX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. PRVRX (254M). PRVRX pays higher dividends than VVIAX: PRVRX (2.52) vs VVIAX (2.18). PRVRX was incepted earlier than VVIAX: PRVRX (10 years) vs VVIAX (25 years). PRVRX (1.75) is less costly to investors than VVIAX (0.05). PRVRX is a more actively managed with annual turnover of: 96.00 vs. VVIAX (9.00). PRVRX has a lower initial minimum investment than VVIAX: PRVRX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 12.03 vs. PRVRX (0.57). VVIAX return over 5 years is better than : 80.13 vs. PRVRX (47.77).
PRVRXVVIAXPRVRX / VVIAX
Total Expense Ratio1.320.052,640%
Annual Report Gross Expense Ratio1.750.053,500%
Fund Existence10 years25 years-
Gain YTD7.4596.198120%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets254M189B0%
Annual Yield % from dividends2.522.18116%
Returns for 1 year0.5712.035%
Returns for 3 years5.9335.1717%
Returns for 5 years47.7780.1360%
Returns for 10 years2.37115.672%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.